2024: Australia’s progress towards hepatitis C elimination annual reportRESEARCH REPORT
The Optimise Study: COVID-19 worry and perceptions about infection and potential severity. (PUBLiC HEALTH REPORT)RESEARCH REPORT
Mapping Australia's hepatitis C healthcare service needsPOLICY BRIEF
The Optimise Study: A rapid survey examining frequency, impacts of long COVID and associated concerns. (PUBLIC HEALTH REPORT)RESEARCH REPORT
The Optimise Study: A rapid survey examining the influence of potential cessation of the Victorian pandemic declaration. (PUBLIC HEALTH REPORT)RESEARCH REPORT
The Optimise Study: COVID-19 testing, test positivity and contacts over time. (PUBLIC HEALTH REPORT)RESEARCH REPORT
The Optimise Study: A rapid survey examining concerns about children returning to school in 2022. (PUBLIC HEALTH REPORT)RESEARCH REPORT
The Optimise Study: Summer 2021-2022 Snapshot. (PUBLIC HEALTH REPORT)RESEARCH REPORT
COVID-19 testing in schools and attitudes and concerns about the current state of the pandemic. (PUBLIC HEALTH REPORT)RESEARCH REPORT
Modelling the Victorian roadmap (PUBLIC HEALTH REPORT)RESEARCH REPORT
The Optimise Study: The impact of COVID19 on income and finances. (PUBLIC HEALTH REPORT)RESEARCH REPORT
The Optimise Study:
Social networks and mixing patternsRESEARCH REPORT
The Optimise Study: Vaccine preparednessRESEARCH REPORT
Know COVID-19: Estimating risks associated with early reopening in VictoriaRESEARCH REPORT
2019: Australia’s progress towards hepatitis C elimination annual reportRESEARCH REPORT
The importance of injecting networksPOLICY BRIEF
Optimising opportunities to provide harm reduction counsellingPOLICY BRIEF
Using social networks to reduce hepatitis C prevalencePOLICY BRIEF
Targeted and comprehensive intervention is vital for hepatitis C eliminationPOLICY BRIEF
A systematic review of the effectiveness of antiviral treatment compared with no treatment for chronic HCV infection.RESEARCH REPORT
Slowly but surely: how to reduce hepatitis C prevalencePOLICY BRIEF
All people who inject drugs should be offered hepatitis C treatmentPOLICY BRIEF